License Pathogen Reduction Technology (PRT) for RED Blood Cell (RBC) Components to Reduce the Risk of Transfusion-Transmitted Infection (TTI) by Recognized, Emerging, Epidemic, and Endemic Pathogens That IS Capable of Treating Over 10 Million RBC COM
Contract Overview
Contract Amount: $32,121,523 ($32.1M)
Contractor: Cerus Corporation
Awarding Agency: Department of Health and Human Services
Start Date: 2024-09-30
End Date: 2029-09-30
Contract Duration: 1,826 days
Daily Burn Rate: $17.6K/day
Official Description: LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM
Place of Performance
Location: California, 94520